View PDF Version - RePub - Erasmus Universiteit Rotterdam
View PDF Version - RePub - Erasmus Universiteit Rotterdam
View PDF Version - RePub - Erasmus Universiteit Rotterdam
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Early on-treatment prediction of response to PEG 119<br />
to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic<br />
hepatitis B. Gut 2007;56:699-705.<br />
27. Peters M. Actions of cytokines on the immune response and viral interactions: an overview.<br />
Hepatology 1996;23:909-16.<br />
28. Marcellin P, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Jin R, Gurel S, Lu ZM, Wu J,<br />
Popescu M, Hadziyannis S. Sustained response of hepatitis B e antigen-negative patients<br />
3 years after treatment with peginterferon alpha-2a. Gastroenterology 2009;136:2169-2179<br />
e1-4.<br />
29. Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis<br />
SJ. Signifi cance of hepatitis B viremia levels determined by a quantitative polymerase chain<br />
reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.<br />
Am J Gastroenterol 2003;98:2261-7.<br />
30. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH. Risk of hepatocellular<br />
carcinoma across a biological gradient of serum hepatitis B virus DNA level. Jama<br />
2006;295:65-73.<br />
31. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level<br />
of circulating hepatitis B viral load. Gastroenterology 2006;130:678-86.<br />
32. Fattovich G, Olivari N, Pasino M, D’Onofrio M, Martone E, Donato F. Long-term outcome of<br />
chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut 2008;57:84-90.<br />
33. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW,<br />
Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N. Peginterferon Alfa-2a,<br />
lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med<br />
2005;352:2682-95.<br />
34. Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, Haussinger D. Response to<br />
interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to<br />
interferon than genotype D. Gut 2005;54:1009-13.<br />
35. Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Luo K, Wang<br />
Y, Hadziyannis S, Wolf E, McCloud P, Batrla R, Marcellin P. Hepatitis B virus surface antigen<br />
levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic<br />
hepatitis B. Hepatology 2009;49:1141-50.<br />
Acknowledgement<br />
In addition to the authors, members of the study group include:<br />
Austria - P Munda, TM Scherzer, K Staufer (Medical University of Vienna, Vienna); W<br />
Vogel, I Graziadei (Innsbruck Medical University, Innsbruck).<br />
Germany - G Gerken (University Hospital Essen, Essen); C Niederau (St. Josef Hospital<br />
Oberhausen, Oberhausen).